Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services

Results At the time of data collection, 17 individuals treating an estimated 1200 AIT patients at 9 out of the 15 "Big 10" universities responded to the questionnaire. 75% of patients received AIT prescribed by allergists not affiliated with the UHS. 70% of the time, AIT extract vial labels were missing one or more of the following recommended components: 2 patient identifiers, dilution of extract in volume/volume (v/v) format with its corresponding color coding, allergen content and expiration date. 16 out of 17 (94%) respondents felt that labels containing all these components would decrease error when administering AIT.